Allergy Diagnostics And Therapeutics Market Size, Share & Trends Analysis Report and Segment Forecast, 2022 | Grand View Research, Inc “Increasing incidences of allergic diseases coupled with demand for in vitro diagnostic blood test is posed to drive the Allergy Diagnostics And Therapeutics industry growth in coming years. ” Global Allergy Diagnostics And Therapeutics Market is expected to reach USD 40.8 billion by 2022, according to a new report by Grand View Research, Inc. Increasing prevalence of allergic conditions and adoption of immunoassay as a viable diagnostic test is expected to serve this market with lucrative future growth opportunities. The prevalence of target diseases such as asthma and food allergies are expected to grow over the next seven years, supported by sedentary and dietary lifestyle habits. In addition, rising indoor, industrial pollution, rapid urbanization in developing countries and increasing greenhouse gas concentrations are expected to increase the prevalence of pollen induced respiratory disorder, thereby boosting the overall market growth over the forecast period. Increasing incidences of allergies has triggered the demand for sensitive, cost effective and accurate diagnostics tools. Manufacturers in congruence with the changing customer preferences are now engaged in constant product development. For instance, the MeDALL allergen-chip for allergy determination is further expected to propel market growth during the next seven years. Browse Details of Report @ http://www.grandviewresearch.com/industry-analysis/allergy-diagnostic-market Further key findings from the study suggest: Consumables being an indispensable diagnostic product segment sell in large volumes and therefore, dominated the market in 2014 with revenue share of over 55.0%. In addition, expensive nature of reagents and their frequent application in diagnostic assay also supports the aforementioned fact. Follow Us: Increasing demand for analyzers and laminators for allergy diagnostics is expected to help this segment grow at a lucrative CAGR of above 12.0% over the forecast period. Increasing awareness pertaining to outsourcing of allergy testing services is anticipated to show upward shift in coming years. Increasing demand for minimally invasive and allergen specific tests is anticipated to serve in vitro allergy diagnostics market with future growth opportunities. The market is expected to grow with CAGR of above 12.0% over the forecast period. Inhaled allergens accounted for the largest share of revenue in 2014 owing to, the growing incidences of respiratory allergies. According to statistics published in 2012 by American Academy of Allergy Asthma and Immunology (AAAAI), around 7.8 million children suffered from respiratory allergies worldwide and the number is expected to increase over the forecast period. Hospitals are the largest consumer of allergy diagnostic products. The segment is anticipated to grow with CAGR of over 11.0% in coming years. Antihistamines were the largest allergy therapeutic segment as of 2014 with share valued at over 17.0% due to associated advantages such as non sedating nature of drugs and minimum side effects with use of second generation antihistamines in allergy treatment. Immunotherapy vaccines are expected to witness lucrative growth owing to extensive R&D coupled with the introduction of sublingual immunotherapy tablets in the treatment of allergic rhinitis. For instance, In April 2014, the U.S. FDA announced the approval of a five-grass pollen sublingual tablet (Ex-Oralair) produced by Stallergenes which are used in the treatment of pollen allergy. Some key players of this market include Thermo Fisher Scientific, Omega Diagnostics, Siemens Healthcare, Stallergenes Greer, Lincoln Diagnostics, bioMerieux, HOB Biotech Group, Alcon Laboratories, Hycor Biomedical and Hitachi Chemical Diagnostics. Industry players are focusing on introducing technologically advanced and innovative products to gain competitive advantage. For instance, in March 2015, Stallergenes received approval for STG 320 in Japan, which is the first sublingual immunotherapy tablet used in the treatment of house dust mite allergy. Grand View Research has segmented the allergy diagnostics and therapeutics market on the basis of product, enduse, diagnostic test, type of allergen, therapeutic class and region: Global Allergy Diagnostics Product Outlook (Revenue, USD Million, 2012 - 2022) Instruments Consumables Services Global Allergy Diagnostics Allergen Type Outlook (Revenue, USD Million, 2012 - 2022) Follow Us: Food Inhaled Drug Other Global Allergy Diagnostics End-use Outlook (Revenue, USD Million, 2012 - 2022) Diagnostic Laboratories Hospitals Academic Research Institutes Global Allergy Diagnostics Test Outlook (Revenue, USD Million, 2012 - 2022) In vivo test o Skin prick test o Intradermal test o Patch test In vitro test Global Allergy Therapeutics Drug Class Outlook (Revenue, USD Million, 2012 - 2022) Antihistamines Decongestants Corticosteroids Mast cell stabilizers Leukotriene Inhibitors Nasal anticholinergics Immunomodulators Autoinjectable Epinephrine Immunotherapy Allergy Diagnostics Regional Outlook (Revenue, USD Million, 2012 - 2022) Follow Us: North America o Europe o U.K o Germany Asia Pacific o Japan o China Latin America o U.S Brazil MEA o South Africa Browse Related Category Reports @ https://www.grandviewresearch.com/industry/clinical-diagnostics Follow Us: Table of Content of Allergy Diagnostics And Therapeutics Market Chapter 1 Methodology and Scope 1.1 Country wise market calculation 1.2 Region based segment share calculation 1.3 Primary Sources 1.4 List of secondary sources Chapter 2 Executive Summary Chapter 3 Allergy Diagnostics Industry Outlook 3.1 Market segmentation 3.2 Market size and growth prospects 3.3 Allergy Diagnostics: Market dynamics 3.3.1 Market driver analysis 3.3.1.1 Increasing incidences of allergy diseases 3.3.1.2 Increasing demand for IVD tests for allergy diagnosis 3.3.1.3 Introduction of technologically advance allergy diagnostics products 3.3.1.4 Growing healthcare expenditure triggering development of effective allergy diagnostic & therapeutic products 3.3.2 Market restraint analysis 3.3.2.1 Low adoption and penetration in developing countries due to high cost of technology 3.3.2.2 Presence of ambiguous regulatory framework 3.4 Industry analysis - Porter’s 3.5 Key Opportunities Prioritized & Platform Positioning 3.5.1 Key Opportunities Prioritized 3.6 Allergy Diagnostics Competitive Landscape, 2014 3.6.1 Company Market Share Analysis, 2014 3.6.2 Competitive Landscape: Market Position Analysis 3.7 Pipleline Aanlysis: Allergy Therapeutics 3.8 Allergy Diagnostics- PESTEL analysis Follow Us: Chapter 4 Allergy Diagnostics Product Outlook 4.1 Allergy diagnostics market share, by product, 2014 & 2022 4.2 Instruments 4.2.1 Instruments market, 2012 - 2022 (USD Million) 4.3 Consumables 4.3.1 Consumables market, 2012 - 2022 (USD Million) 4.4 Services 4.4.1 Services market, 2012 - 2022 (USD Million) Chapter 5 Allergy Diagnostics Allergen Type Outlook 5.1 Allergy diagnostics market share, by allergen type, 2014 & 2022 5.2 Food Allergen 5.2.1 Food Allergen market, 2012 - 2022 (USD Million) 5.3 Inhaled Allergen 5.3.1 Inhaled allergen market, 2012 - 2022 (USD Million) 5.4 Drug Allergen 5.4.1 Drug allergen market, 2012 - 2022 (USD Million) 5.5 Other 5.5.1 Other market, 2012 - 2022 (USD Million) Chapter 6 Allergy Diagnostics End-use Outlook 6.1 Global allergy diagnostics market share, by end-use, 2014 & 2022 6.2 Academic Research Institutes 6.2.1 Academic research institutes market, 2012 - 2022 (USD Million) 6.3 Hospitals 6.3.1 Hospitals market, 2012 - 2022 (USD Million) 6.4 Diagnostic Laboratories 6.4.1 Diagnostic laboratories market, 2012 - 2022 (USD Million) Chapter 7 Allergy Diagnostics Test Outlook 7.1 Global allergy diagnostics market share, by test, 2014 & 2022 Follow Us: 7.2 In vivo test 7.2.1 In vivo test market, 2012 - 2022 (USD Million) 7.2.2 Skin prick test 7.2.2.1 Skin prick test market, 2012 - 2022 (USD Million) 7.2.3 Intradermal test 7.2.3.1 Intradermal test market, 2012 - 2022 (USD Million) 7.2.4 Patch test 7.2.4.1 Patch test market, 2012 - 2022 (USD Million) 7.3 In vitro test 7.3.1 In vitro test market, 2012 - 2022 (USD Million) Chapter 8 Allergy Therapeutics Drug Class Outlook 8.1 Global allergy therapeutics market share, by drug class, 2014 & 2022 8.2 Antihistamines 8.2.1 Antihistamines market, 2012 - 2022 (USD Million) 8.3 Corticosteroids 8.3.1 Corticosteroids market, 2012 - 2022 (USD Million) 8.4 Mast Cell Stabilizers 8.4.1 Mast Cell Stabilizers market, 2012 - 2022 (USD Million) 8.5 Leukotriene Inhibitors 8.5.1 Leukotriene Inhibitors market, 2012 - 2022 (USD Million) 8.6 Nasal anticholinergics 8.6.1 Nasal anticholinergics market, 2012 - 2022 (USD Million) 8.7 Decongestants 8.7.1 Decongestants market, 2012 - 2022 (USD Million) 8.8 Immunomodulators 8.8.1 Immunomodulators market, 2012 - 2022 (USD Million) 8.9 Autoinjectable Epinephrine 8.9.1 Autoinjectable epinephrine market, 2012 - 2022 (USD Million) 8.10 Immunotherapy 8.10.1 Immunotherapy market, 2012 - 2022 (USD Million) Follow Us: Chapter 9 Allergy Diagnostics Regional Outlook 9.1 Allergy Diagnostics market share, by region, 2014 & 2022 9.2 North America 9.2.1 North America allergy diagnostics market, 2012 - 2022 (USD Million) 9.2.2 North America allergy therapeutics market, 2012 - 2022 (USD Million) 9.2.3 U.S. 9.2.3.1 U.S. Allergy Diagnostics market, 2012 - 2022 (USD Million) 9.2.3.2 U.S. allergy therapeutics market, 2012 - 2022 (USD Million) 9.3 Europe 9.3.1 Europe Allergy Diagnostics market, 2012 - 2022 (USD Million) 9.3.2 Europe allergy therapeutics market, 2012 - 2022 (USD Million) 9.3.3 Germany 9.3.3.1 Germany Allergy Diagnostics market, 2012 - 2022 (USD Million) 9.3.3.2 Germany allergy therapeutics market, 2012 - 2022 (USD Million) 9.3.4 UK 9.3.4.1 UK allergy diagnostics market, 2012 - 2022 (USD Million) 9.3.4.2 UK allergy therapeutics market, 2012 - 2022 (USD Million) 9.4 Asia Pacific 9.4.1 Asia Pacific allergy diagnostics market, 2012 - 2022 (USD Million) 9.4.2 Asia Pacific allergy therapeutics market, 2012 - 2022 (USD Million) 9.4.3 Japan 9.4.3.1 Japan allergy diagnostics market, 2012 - 2022 (USD Million) 9.4.3.2 Japan allergy therapeutics market, 2012 - 2022 (USD Million) 9.4.4 China 9.4.4.1 China allergy diagnostics market, 2012 - 2022 (USD Million) 9.4.4.2 China allergy therapeutics market, 2012 - 2022 (USD Million) 9.5 Latin America 9.5.1 Latin America allergy diagnostics market, 2012 - 2022 (USD Million) 9.5.2 Latin America allergy therapeutics market, 2012 - 2022 (USD Million) 9.5.3 Brazil Follow Us: 9.5.3.1 Brazil allergy diagnostics market, 2012 - 2022 (USD Million) 9.5.3.2 Brazil allergy therapeutics market, 2012 - 2022 (USD Million) 9.6 MEA 9.6.1 MEA allergy diagnostics market, 2012 - 2022 (USD Million) 9.6.2 MEA allergy therapeutics market, 2012 - 2022 (USD Million) 9.6.3 South Africa 9.6.3.1 South Africa allergy diagnostics market, 2012 - 2022 (USD Million) 9.6.3.2 South Africa allergy therapeutics market, 2012 - 2022 (USD Million) Chapter 10 Competitive Landscape 10.1 bioMerieux 10.1.1 Company Overview 10.1.2 Financial Performance 10.1.3 Product Benchmarking 10.1.4 Strategic Initiatives 10.2 Danaher Corporation 10.2.1 Company Overview 10.2.2 Beckman Coulter 10.2.3 Financial Performance 10.2.4 Product Benchmarking 10.2.5 Strategic Initiatives 10.3 Thermo Fisher Scientific 10.3.1 Company Overview 10.3.2 Financial Performance 10.3.3 Product Benchmarking 10.3.4 Strategic Initiatives 10.4 Stallergenes Greer 10.4.1 Company Overview 10.4.2 Financial Performance 10.4.3 Product Benchmarking 10.4.4 Strategic Initiatives Follow Us: 10.5 Hitachi Chemical Diagnostics 10.5.1 Company Overview 10.5.2 Financial Performance 10.5.3 Product Benchmarking 10.5.4 Strategic Initiatives 10.6 Siemens Healthcare 10.6.1 Company Overview 10.6.2 Financial Performance 10.6.3 Service Benchmarking 10.6.4 Strategic Initiatives 10.7 Omega Diagnostics 10.7.1 Company Overview 10.7.2 Financial Performance 10.7.3 Product Benchmarking 10.7.4 Strategic Initiatives 10.8 Hycor Biomedical 10.8.1 Company Overview 10.8.2 Financial Performance 10.8.3 Product Benchmarking 10.8.4 Strategic Initiatives 10.9 Lincoln Diagnostics 10.9.1 Company Overview 10.9.2 Financial Performance 10.9.3 Product Benchmarking 10.9.4 Strategic Initiatives 10.10 HOB Biotech Group 10.10.1 Company Overview 10.10.2 Financial Performance 10.10.3 Product Benchmarking 10.10.4 Strategic Initiatives 10.11 Alcon Laboratories, Inc. Follow Us: 10.11.1 Company Overview 10.11.2 Financial Performance 10.11.3 Product Benchmarking 10.11.4 Strategic Initiatives About Us: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: [email protected] For More Information: https://www.grandviewresearch.com Blog: https://healthcareforecastreport.blogspot.com/ Follow Us:
Global allergy diagnostics and therapeutics market is expected to reach USD 40.8 billion by 2022, according to a new report by Grand View Research, Inc.
© Copyright 2024 Paperzz